The Report Guru

According to the new market research report the leukemia therapeutics market is projected to reach USD 17.1 billion by 2024 from USD 12.3 billion in 2019, at a CAGR of 6.8% during the forecast period. The market for leukemia therapeutics is mainly driven by the high prevalence of the disease. Asia and Europe have high prevalence rates of leukemia, followed by North America, making these regions the key markets for therapeutics. Other factors driving the leukemia therapeutics market growth include the introduction of innovative therapies. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223 However, complexities in manufacturing serve as a key restraint to market growth. Companies in this market are required to comply with stringent regulations during product manufacturing and testing, which considerably slows the introduction of new products in the market. •Based on the type of leukemia, the leukemia therapeutics market is segmented into acute l

Factors such as rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, increasing outsourcing of customization and fabrication of restorative and prosthetic products to restorative dentistry, and increasing demand for restorative dentistry are driving the growth of the global restorative dentistry market. According to the new market research report restorative dentistry market is expected to reach USD 21.27 Billion by 2022 from an estimated USD 15.60 Billion in 2017, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210042423 Players in the global restorative dentistry market, such as DENTSPLY SIRONA Inc. (US), Institut Straumann (Switzerland), Mitsui Chemicals, Inc. (Japan), Ivoclar Vivadent AG (Liechtenstein), Zimmer Biomet Holdings, Inc. (U

Market Growth Factors- Growth in Neuroscience Antibodies and Assays Market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. According to research report the Neuroscience Antibodies Market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=129888612 Top Segments - The Neuroscience Antibodies Market are segmented based on product, technology, application, end user, and region. Based on product, the Neuroscience Antibodies Market are segmented into consumables and instruments. The consumables segment is expected to account for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. The consistent usage of consumables and their frequent purchases, and rising government initiatives i

Emergency medical procedures involve on-the-spot diagnosis and treatment of the critically ill or injured. The emergency medical services EMS products market includes medical products and equipment used for such urgent procedures. According to research report the EMS Products Market is expected to reach USD 25.56 billion by 2022 from USD 19.01 billion in 2017, at a CAGR of 6.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195094847 Growth in this market is primarily driven by the high demand for emergency care, increasing incidence of trauma injuries, and growing investments by government bodies on healthcare infrastructure development (including the establishment of and improvements in emergency care infrastructure). However, the high cost of emergency equipment is one of the major factors restraining the growth of this market. The global EMS products market is segmented by type, application, end user, and region. By applicat

Growth Factors- Increasing utilization of smart devices, the availability of big data in healthcare, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global market. Market Size- According to research report Healthcare Middleware Market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258951459 This market is segmented on the basis of type, application, deployment model, end user, and region. By type, the market is segmented into communication middleware, platform middleware, integration middleware, and other middleware. The platform middleware segment is expected to command the largest share of the healthcare middleware market in 2018. Factors such as ease of deployment and use, easy interoperability, data security, portability, and cost-effectiveness are dri

Oral hygiene awareness is one of the major contributors to market growth in the overall oral care market . Factors such as the rise in the prevalence of dental diseases and the growing awareness about oral healthcare are expected to drive the growth of the market. Global Market Size - The global oral care market is projected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 Top Leaders - • Colgate-Palmolive Company (US) is a global leader in the toothpastes and manual toothbrushes market. The company provides advanced oral care products for kids and adults. High investment in R&D enables the company to develop new and advanced toothpastes and toothbrushes for the oral care market. The company invested approximately USD 289 million in 2016 in R&D. Though the company has a rich product portfolio of toothpastes and toothbrushes, the company does no

Factors such as the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs are driving the growth of the operating room integration market during the forecast period. Market Size- According to a new market research report Operating Room Integration Market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667 Key Market Players- Stryker Corporation (US), STERIS (US), KARL STORZ (Germany), and Olympus (Japan) are the key players operating in this market. Other prominent players in the market include Getinge (Sweden), Alvo Medical (Poland), Skytron (US), Merivaara (Finland), Brainlab (Germany), TRILUX Medical (Germany), caresyntax (US), Sony (Japan), Barco (Belgium), Arthrex (US), and R

The growing demand for advanced clinical-grade wearables to streamline complex operational procedures among healthcare organizations has led to a number of product launches & enhancements in recent years. Companies focus on launching innovative solutions to gain a competitive edge and exploit market growth opportunities offered by advanced and next-generation wearables. According to research report the medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a CAGR of 21.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876 The prominent players in this market are Medtronic plc. (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Biotelemetry Inc.(US), Apple, Inc. (US ), Dexcom Inc. (US), Abbott Laboratories(US), Masimo Corporation(US), GE Healthcare (US), Bio-Beat Technologies (Israel), iRhythm Technologies, Inc.(US), VitalConnec

According to research report the neurodiagnostics market is projected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229090425 The growth of this market is primarily driven by the increasing prevalence of neurological disorders & diseases, technological advancements, growing patient emphasis on effective & early disease diagnosis, the growing number of diagnostic centers & hospitals, and the use of biomarker profiling for disease diagnostics. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth. Some prominent players in the neurodiagnostics market are GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), and Hitachi, Ltd. (Japan). An analysis

According to research report the Clinical Microbiology Market is projected to reach $4.9 billion by 2023 from $3.6 billion in 2018, at a CAGR of 6.4% from 2018 to 2023. Growth in the clinical microbiology market can be attributed to the technological advancements in the disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis. On the other hand, reimbursement concerns and unfavorable regulatory scenario are expected to limit market growth to a certain extent. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 Recent Developments: > In 2018, Roche Diagnostics (Switzerland) launched the cobas TV/MG assay > In 2017, bioMérieux (UK) received FDA clearance for expanded pathogen identification capability of VITEK MS > In 2017, Hologic (US) collaborated with Seegene Inc. (South Korea) to develop and suppl

According to research report the sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The sinus dilation devices market, by product, is segmented into balloon sinus dilation devices, endoscopes, sinus stents/implants, and handheld instruments. In 2018, the sinus stents/implants segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to their drug eluting functionality and reduced scarring and inflammation. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 High prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries are the key factors driving the growth of this market. Based on patient care setting, the

The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051 Elastography imaging uses high-frequency soundwaves and mechanical waves to create images of the inside of the body. Currently, ultrasound is one of the most-preferred elastography imaging techniques as compared to other imaging modalities such as MRI and CT, owing to its minimally invasive nature, lower procedural cost, less/no side effects, and ease of use. The major elastography imaging vendors include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands),

The immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The immunoassays market is consolidated in nature due to the presence of a large number of players. Key players in the market include Abbott Laboratories (US), Roche (Switzerland), Siemens (Germany), Danaher Corporation (US), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Merck (Germany), Agilent Technologies (US), Quidel Corporation (US), PerkinElmer (US), Mindray (China), and Bio-Techne Corporation (US). Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The key strategies followed by most companies in the immunoassays market are product launches and partnerships, collaborations, & agreements. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 20

Factors such as the growing need to manage regulatory compliance through the use of eHealth solutions, the need to curtail escalating healthcare costs, increasing government initiatives supporting the use of eHealth solutions and services, the high prevalence of chronic diseases, shift towards patient-centric healthcare delivery, and rising usage of big data are majorly driving the growth of this market. According to the new market research report eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 Emerging markets such as China, India, and Australia have a high potential for growth in the eHealth market mainly due to the rising government investments and reforms to modernize healthcare infrastructure, growing purchasing power of consumers, increasing government initiatives for infrastructural development, and the rising nee

According to research report the cardiac monitoring devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 The major players in the cardiac monitoring devices market include Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), Koninklijke Philips (Netherlands), and Hill-Rom Holdings (US). Various growth strategies have been adopted by these players, such as product launches, contracts, agreements, collaborations, partnerships, and acquisitions to increase their presence in the global cardiac monitoring devices market.

Surgical Microscopes Market Market growth factors – • The increasing use of fluorescence image-guided surgery (FIGS), • Increase in the number of surgeries and growing demand for MIS, • Advancements in healthcare facilities, • Technological advancements, and customized microscopy solutions According to research report the global surgical microscopes market is projected to reach USD 915.6 million by 2021 from USD 508.1 million in 2016, growing at a CAGR of 12.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179225920 Geographical overview - The Asia-Pacific region (comprising China, India, and RoAPAC) is expected to grow at the highest CAGR during the forecast period. The high growth in the regional segment can primarily be attributed to the presence of high-growth surgical microscopes market such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In recent years, the Asia-Pacific

Thrombectomy Devices Market Over the last few years, the thrombectomy devices market has witnessed significant advancements in terms of the product development and commercialization. The major factors driving the growth of the market are growing target patient population, ongoing technological advancements in thrombectomy devices, favorable medical reimbursement scenario, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets. According to research report thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801 In this report, the market has been segmented by type, application, end user, and region. In 2016, North America held the largest share of the market. • Based on type, the market is segmented into aspiration, mechanical, rheolytic,

Factors such as the rise in the prevalence of dental diseases and the growing awareness about oral healthcare are expected to drive the growth of the market. According to research report the global oral care market is expected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 In this report, the oral care market is categorized based on product, distribution channel, and region. Based on product category, this market is segmented into toothpastes, toothbrushes & accessories, mouthwashes/rinses, dental accessories/ancillaries, denture products, and dental prosthesis cleaning solutions. The toothbrushes and accessories segment is projected to register the highest CAGR during the forecast period. The high growth of this segment is mainly attributed to the increasing adoption of electronic and battery-powered toothbrushes. In recent years, product inno

The major factors driving the growth of the Single Use Bioreactors include the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in cultivating marine organisms, and reduced impact on the environment. According to research report Single Use Bioreactors Market is expected to reach USD 2,685.1 Million by 2022, grow at a CAGR of 21.9% from 2017 to 2022. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750 Most companies focus on launching new products to compete in the market. The players also focus on increasing their presence in high-growth markets through agreements, expansions, and acquisitions. Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US) focus on product launches and enhancements to strengthen their position in the market. Thermo Fisher Scientific, Inc. will hold the leadership position in the Single Use B

According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Growth in the contrast media market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations. However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 The major players in the global contrast media market are GE Healthcare (US), Bayer (Germany), Bracco Imaging S.p.A (Italy). An analysis of the market developments between 2016 and 2019 revealed that product launches, partnerships, expansions, and strategic acquisitions were adopted by market players to strengthe

The factors driving the growth of this market are the technological advancements in sternotomy techniques, increasing target patient population coupled with the subsequent increase in the number of surgical procedures, and growing availability of medical reimbursements across major markets. According to the new market research report Sternal Closure Systems Market is estimated to be valued at USD 2.02 billion in 2018 and is projected to reach USD 2.61 billion by 2023, at a CAGR of 5.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152164684 In the last decade, the sternal closure systems market has witnessed several mergers and acquisitions. For instance, Vance Street Capital LLC and A&E Medical Corporation (US) acquired Medical Concepts (Netherlands), with the aim to increase their product portfolio of single-use medical products in 2016. In this report, the market has been segmented by product, procedure, material, and region. As of